The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancer.
Serdar ArıcıSevda S KaryagarSavas KaryagarCaglayan GeredeliRuhper CekinŞaban SeçmelerMuhammed M AtciAbdullah SakinŞener CihanPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
Our study results suggest that higher pretreatment metabolic tumor volume values are predictive on no pathologic response in patients treated with neoadjuvant chemotherapy for breast cancer.